Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Late PCI in STEMI without Viability
NCT05160311Unknown
- Sponsor
- Instituto Dante Pazzanese de Cardiologia
- Start
- Aug 2021
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Randomised, open-label trial in ST elevation myocardial infarction (STEMI) and myocardial dysfunction (2 arms), sponsored by Instituto Dante Pazzanese de Cardiologia. Primary endpoint: Reverse myocardial remodeling assessed by End Systolic Volume (ESV) at 6 months. Status: unknown.
02
Conditions
ST elevation myocardial infarction (STEMI)myocardial dysfunction
Beyond the preview
Go deeper on NCT05160311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05160311.